Source:http://linkedlifedata.com/resource/pubmed/id/21314886
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7
|
| pubmed:dateCreated |
2011-9-14
|
| pubmed:abstractText |
• To study the pharmacokinetic and toxicity profile of intravesically administered TMX-101, with its active ingredient R-837, a synthetic Toll-like receptor (TLR)-7 agonist, in a pig model.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
1464-410X
|
| pubmed:author | |
| pubmed:copyrightInfo |
© 2011 THE AUTHORS; BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.
|
| pubmed:issnType |
Electronic
|
| pubmed:volume |
108
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1210-4
|
| pubmed:meshHeading | |
| pubmed:year |
2011
|
| pubmed:articleTitle |
Pharmacokinetics and toxicity of intravesical TMX-101: a preclinical study in pigs.
|
| pubmed:affiliation |
Radboud University Nijmegen Medical Centre, Urology, Nijmegen, The Netherlands. h.arentsen@uro.umcn.nl
|
| pubmed:publicationType |
Journal Article
|